Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase

European Journal of Medicinal Chemistry

Volumn 45, Issue 1, 2010, Pages 186-192

  Katalinić, Maja ^a   Rusak, Gordana ^b   Domaćinović Barović, Jelena ^a,b   Šinko, Goran ^a   Jelić, Dubravko ^c   Antolović, Roberto ^d   Kovarik, Zrinka ^a  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c GLAXOSMITHKLINE   (United Kingdom)

^d University of Rijeka   (Croatia)

Author keywords

Acetylcholinesterase; Cholinesterase; Cytotoxicity; Flavonoids; Reversible inhibition; UV VIS spectra

Indexed keywords

ACETYLCHOLINESTERASE; APIGENIN; CHOLINESTERASE; FISETIN; FLAVONOID; GALANGIN; KAEMPFEROL; LUTEOLIN; MYRICETIN; QUERCETIN; RUTOSIDE;

ARTICLE; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; HYDROGEN BOND; IC 50; ULTRAVIOLET RADIATION;

ACETYLCHOLINESTERASE; BUTYRYLCHOLINESTERASE; CELL LINE, TUMOR; CHOLINESTERASE INHIBITORS; FLAVONOIDS; HUMANS; MODELS, MOLECULAR; PROTEIN CONFORMATION; SUBSTRATE SPECIFICITY;

EID: 72049088515     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.09.041     Document Type: Article

References (25)

1. Ingkaninan K., de Best C.M., van der Heijden R., Hofte A.J.P., Karabatak B., Irth H., Tjaden U.R., van der Greef J., and Verpoorte R. J. Chromatogr. A 872 (2000) 61-73
2. Mesulam M.M., Guillozet A., Shaw P., Levey A., Duysen E.G., and Lockridge O. Neuroscience 110 (2002) 627-639
3. Darvesh S., Hopkins D.A., and Geula C. Nat. Neurosci. 4 (2003) 131-138
4. Greig N.H., Sambamurti K., Yu Q.-S., Perry T.A., Holloway H.W., Haberman F., Brossi A., Ingram D.K., and Lahiri D.K. Butyrylcholinesterase: its selective inhibition and relevance to alzheimer's disease therapy. In: Giacobini E. (Ed). Butyrylcholinesterase: Its Function and Inhibitors. first ed. (2003), Martin Dunitz, Taylor and Francis Group Plc, United Kindom pp. 69-90
5. Geula C., and Darvesh S. Drugs Today 40 (2004) 711-721
6. In: Rice-Evans C., and Packer L. (Eds). Flavonoids in Health and Disease. second ed. (2003), Marcel Dekker Inc., New York/Basel
7. Rusak G., Gutzeit H.O., and Ludwig-Mu{combining double acute accent}ller J. Nutr. Res. 25 (2005) 141-153
8. Rusak G., Gutzeit H.O., and Ludwig-Mu{combining double acute accent}ller J. Food Technol. Biotechnol 40 (2002) 267-273
9. Čalić M., Jelić D., Antolović R., Nujić K., Marjanović N., Stupin Polančec D., Vikić-Topić S., and Verbanac D. Croat. Chem. Acta 78 (2005) 367-374
10. Colic M., and Pavelic J K. Mol. Med. 78 (2000) 333-336
11. Gutzeit H.O., Tokalov S.V., Ludwig-Müller J., and Rusak G. Croat. Chem. Acta 78 (2005) 337-342
12. Kovarik Z. Period. Biol. 101 (1999) 7-15
13. Ji H.-F., and Zhang H.-Y. J. Mol. Struc.-Theochem 767 (2006) 3-9
14. Boulton D.W., Walle U.K., and Walle T. J. Pharm. Pharmacol. 51 (1999) 353-359
15. MoonHeo Y., SuSohn J., and WilliamAu W. Mutat. Res.-Rev. Mutat.Res. 488 (2001) 135-150
16. Harwood M., Danielewska-Nikiel B., Borzelleca J.F., Flamm G.W., Williams G.M., and Lines T.C. Food Chem. Toxicol. 45 (2007) 2179-2205
17. Hollman P.C.H., van Trijp J.M.P., Buysman M.N.C.P., v.d. Gaag M.S., Mengelers M.J.B., de Vries J.H.M., and Katan M.B. FEBS Lett. 418 (1997) 152-156
18. Youdim K.A., Shukitt-Hale B., and Joseph J.A. Free Radical Biol. Med. 37 (2004) 1683-1693
19. Rossi L., Mazzitelli S., Arciello M., Capo C.R., and Rotilio G. Neurochem. Res. 33 (2008) 2390-2400
20. Mattson M.P. Nature 430 (2004) 631-639
21. Ellman G.L., Courtney K.D., Andres V., and Featherstone R.M. Biochem. Pharmacol. 7 (1961) 88-95
22. Hunter A., and Downs C.E. J. Biol. Chem. 157 (1945) 427-446
23. Ngamelue M.N., Homma K., Lockridge O., and Asojo O.A. Acta Crystallogr. 63 (2007) 723-727
24. Mosmann T. J. Immunol. Methods 65 (1983) 55-63
25. Verbanac D., Jelić D., Stepanić V., Tatić I., Žiher D., and Koštrun S. Croat. Chem. Acta 78 (2005) 133-139